deltatrials
Terminated PHASE1 INTERVENTIONAL 4-arm NCT02388152

Study to Evaluate the Safety and Tolerability of a New Drug Named Lu AF20513 in Patients With Mild Alzheimer's Disease

Interventional, Open-label, Multiple-immunization Extension Study on the Safety, Tolerability and Immunogenicity of Lu AF20513/Adjuvant in Patients With Alzheimer's Disease

Sponsor: H. Lundbeck A/S

Conditions Alzheimer Disease
Interventions Lu AF20513, double high dose Lu AF20513, high dose Lu AF20513, low dose Lu AF20513, medium dose
Updated 18 times since 2017 Last updated: Nov 27, 2019 Started: Mar 31, 2015 Primary completion: Jul 4, 2019 Completion: Jul 4, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

New data: The study was terminated based on new efficacy data from another study

Other terminated trials from H. Lundbeck A/S

See all terminations from H. Lundbeck A/S

Other Alzheimer Disease trials with similar outcome

Browse all Alzheimer Disease trials

Listed as NCT02388152, this PHASE1 trial focuses on Alzheimer Disease and remains terminated or withdrawn. Sponsored by H. Lundbeck A/S, it has been updated 18 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Apr 2017 · 3 months · monthly snapshot~Apr 2017 – ~Apr 2018 · 12 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Oct 2018 · 2 months · monthly snapshot~Oct 2018 – ~Dec 2018 · 2 months · monthly snapshot~Dec 2018 – ~Mar 2019 · 3 months · monthly snapshot~Mar 2019 – ~Apr 2019 · 31 days · monthly snapshot~Apr 2019 – ~Jun 2019 · 2 months · monthly snapshot~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Dec 2019 · 4 months · monthly snapshot~Dec 2019 – ~Jan 2021 · 13 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

18 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE1

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1

  4. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE1

  5. Dec 2019 — Jan 2021 [monthly]

    Terminated PHASE1

▶ Show 13 earlier versions

  1. Aug 2019 — Dec 2019 [monthly]

    Terminated PHASE1

    Status: Active Not Recruiting → Terminated

  2. Jul 2019 — Aug 2019 [monthly]

    Active Not Recruiting PHASE1

  3. Jun 2019 — Jul 2019 [monthly]

    Active Not Recruiting PHASE1

  4. Apr 2019 — Jun 2019 [monthly]

    Active Not Recruiting PHASE1

  5. Mar 2019 — Apr 2019 [monthly]

    Active Not Recruiting PHASE1

  6. Dec 2018 — Mar 2019 [monthly]

    Active Not Recruiting PHASE1

  7. Oct 2018 — Dec 2018 [monthly]

    Active Not Recruiting PHASE1

  8. Aug 2018 — Oct 2018 [monthly]

    Active Not Recruiting PHASE1

  9. Jun 2018 — Aug 2018 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  10. May 2018 — Jun 2018 [monthly]

    Recruiting PHASE1

    Status: Active Not Recruiting → Recruiting

  11. Apr 2018 — May 2018 [monthly]

    Active Not Recruiting PHASE1

  12. Apr 2017 — Apr 2018 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  13. Jan 2017 — Apr 2017 [monthly]

    Recruiting PHASE1

    First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • H. Lundbeck A/S
Data source: H. Lundbeck A/S

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations